335810 — Precision Biosensor Balance Sheet
0.000.00%
- KR₩30bn
- KR₩44bn
- KR₩19bn
Annual balance sheet for Precision Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 23,904 | 22,548 | 8,560 | 6,427 | 3,723 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,542 | 2,822 | 2,128 | 2,512 | 3,159 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32,379 | 33,295 | 20,771 | 18,445 | 16,371 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9,207 | 15,490 | 27,806 | 33,469 | 30,836 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 42,279 | 55,718 | 59,010 | 62,478 | 52,039 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,830 | 2,152 | 20,041 | 13,345 | 19,391 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,058 | 17,365 | 25,634 | 30,451 | 26,341 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 37,221 | 38,353 | 33,375 | 32,027 | 25,698 |
Total Liabilities & Shareholders' Equity | 42,279 | 55,718 | 59,010 | 62,478 | 52,039 |
Total Common Shares Outstanding |